Clearside Biomedical, Inc. (CLSD) Reports Q2 Loss, Lags Revenue Estimates
CLSDClearside Biomedical(CLSD) ZACKS·2024-08-13 06:26

Clearside Biomedical, Inc. (CLSD) came out with a quarterly loss of 0.10pershareversustheZacksConsensusEstimateofalossof0.10 per share versus the Zacks Consensus Estimate of a loss of 0.14. This compares to loss of 0.15pershareayearago.Thesefiguresareadjustedfornon−recurringitems.Thisquarterlyreportrepresentsanearningssurpriseof28.570.15 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 28.57%. A quarter ago, it was expected that this company would post a loss of 0.14 per share when it actually produced a loss of $0.17, delivering a surprise of -21.43%.Over the last four quarters, the company ...